Arbor Biotechnologies
This role involves developing, optimizing, and running histology assays on preclinical CNS tissue to generate evidence for gene editing programs. The position requires quantifying assay readouts, analyzing data, and presenting results to support decision-making for in vivo studies. The role reports to the Senior Scientist, In Vivo Pharmacology and is based on-site in Cambridge.
At Arbor® Biotech, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arbor Biotechnologies.